Clinical trial Recruiting at 1 site Interventional Ages 40 and up Women only

Different exercise programs during perimenopause

Official title: Perimenopause: Window for Exercise and Resilience Pilot Study

Run by University of Toronto · NCT07132385 · Data updated 2026-11-12

Over six weeks, this trial will try following Health Canada exercise guidelines, doing high-intensity interval training (HIIT), or doing stretching to see which is easiest and most enjoyable for women in perimenopause who have menopause symptoms.

Quick facts

Study typeInterventional
Ages40 Years and up
SexWomen only
Enrollment30 (estimated)
SponsorUniversity of Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 15, 2026
Trial IDNCT07132385 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Biological females aged 40 or older in early or late perimenopause who are experiencing menopause symptoms, are sedentary (<30 minutes moderate-to-vigorous activity per week), have BMI ≥25 kg/m2, and have abdominal obesity as defined by the protocol.

Probably not a fit

People who have had reproductive surgeries (e.g., hysterectomy or oophorectomy), existing cardiovascular disease or type 2 diabetes, or who do not meet the sedentary/overweight abdominal obesity criteria are unlikely to benefit or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are randomized to one of three six-week interventions: guideline-based moderate-intensity continuous training, high-intensity interval training (HIIT), or stretching. Before and after the intervention, researchers collect questionnaires on menopause symptoms, stress, and quality of life, measure body composition with a BodPod, and test insulin sensitivity with an oral glucose tolerance test and blood sampling. Adherence and participant-reported ease and enjoyment of the assigned program are recorded after the intervention. The results will inform design and selection of interventions for a larger trial targeting symptom relief and cardiometabolic health in perimenopause.

Why it matters

Potential benefit: If successful, the study could identify which type of exercise is most acceptable and likely to be continued, helping reduce menopause symptoms and improve cardiometabolic health during perimenopause.

How similar studies have gone: Previous research shows exercise can help menopausal symptoms and that HIIT improves fitness and insulin sensitivity in other populations, but direct head-to-head comparisons specifically in perimenopausal women are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Biological females in early and late perimenopause. Menopausal stage will be defined according to the Stages of Reproductive Aging Workshop +10 (STRAW+10). According to STRAW+10, perimenopause is characterized by menstrual cycle irregularity, specifically defined as having bleeding in the previous 12 months but at least a 7-day difference from usual menstrual cycle length
* Experiencing menopause symptoms (e.g., hot flashes, night sweats, joint stiffness)
* Aged 40 years or older
* Multiple risk factors for cardiometabolic disease, namely being sedentary (\<30 min of moderate-vigorous physical activity/week), having a BMI ≥25 kg/m2, and a waist circumference indicative of abdominal obesity, specific to BMI (e.g., BMI 25-29.9: WC: 90cm; BMI 30-34.9: WC: 105cm; BMI 35-35.9: WC:115cm).

Exclusion Criteria:

* History of reproductive surgeries including oophorectomy, hysterectomy, ablation or gender-affirming.
* Diagnosis of cardiovascular disease, type 2 diabetes, non-alcoholic fatty liver disease, cancer (except for non-melanoma skin cancer), respiratory disease (e.g., Chronic Obstructive Pulmonary Disease or severe or uncontrolled asthma), uncontrolled hyper- or hypogonadism (change in medication or dosage in last 6 months and with major symptoms), and/or Polycystic Ovary Syndrome
* Major signs or symptoms (regardless of known diagnosis) of cardiovascular diseases, diabetes, or renal disease
* The use of medication that could impact blood glucose
* Pregnant or post-partum \<12 months, lactating or breast feeding within 3 months of the start of study
* Recreational smoking (e.g., tobacco, smoking)
* Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins)
* Using transdermal hormones, taking exogenous hormones, or receiving exogenous hormones from other means (e.g., intrauterine device)
* Significant weight loss (i.e., \>5 kg) in past 3 months or currently taking weight loss medications

Where it's running

  • Goldring Centre for High Performance Sport
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.